Viewing Study NCT00665093


Ignite Creation Date: 2025-12-25 @ 1:25 AM
Ignite Modification Date: 2026-03-09 @ 7:04 AM
Study NCT ID: NCT00665093
Status: COMPLETED
Last Update Posted: 2017-01-09
First Post: 2008-04-22
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Observational Study of Patients Using NovoMix® 30 or Levemir® for Treatment of Type 1 or Type 2 Diabetes
Sponsor: Novo Nordisk A/S
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module